Tesla debuts $35,000 Model 3, sees loss in first quarter
SAN FRANCISCO (Reuters) – Tesla Inc said on Thursday it would offer a $35,000 version of its Model 3 sedan with a delivery time of two to four weeks, while…
Parkinson’s drug trial offers glimmer of hope for brain cells
LONDON, Feb 27 (Reuters) – An experimental drug could offer hope for restoring damaged brain cells in Parkinson’s patients, scientists said on Wednesday, although they cautioned that a clinical trial…
Novartis gene therapy would be cost effective up to $900,000: U.S. group
(Reuters) – An experimental gene therapy for spinal muscular atrophy (SMA) developed by Swiss drugmaker Novartis AG would be worth a price of $310,000 to $900,000, according to an independent…
Samsung announces folding phone with 5G at nearly $2,000
SAN FRANCISCO (Reuters) – Samsung Electronics Co Ltd on Wednesday unveiled a nearly $2,000 folding smartphone in a bid to top the technology of Apple Inc and Chinese rivals and…
Ford to close oldest Brazil plant, exit South America truck biz
SAO PAULO/DETROIT (Reuters) – Ford Motor Co said on Tuesday it will close its oldest factory in Brazil and exit its heavy commercial truck business in South America, a move…
Honda to shut UK car plant in 2022 with the loss of 3,500 jobs
LONDON (Reuters) – Japanese car maker Honda is set to announce it’s closing its only British car plant in 2022 with the loss of 3,500 jobs, a lawmaker told Reuters,…
Honda to close UK car plant with the loss of 3,500 jobs
LONDON (Reuters) – Japanese carmaker Honda is set to announce the closure of its only British car plant in 2022 with the loss of 3,500 jobs, a lawmaker told Reuters,…
Britain does not support total Huawei network ban: sources
(Reuters) – British security officials do not support a full ban of Huawei from national telecoms networks despite U.S. allegations the Chinese firm and its products could be used by…
As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices
TOKYO (Reuters) – Japanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an octogenarian and wondering whether taxpayers might object to helping fund treatment, which at the time…
Famed Cullinan mine banks on big diamonds to drive down debt
CULLINAN, South Africa (Reuters) – The owner of one of the world’s most famous diamond mines could be about a decade away from clearing its multi-million-dollar debts, in a sign…